Heim J, Vasquez JG, Schenkel B, Bhatia N. Patients’ quality of life in a Phase 4 real-world study of tildrakizumab in moderate-to-severe plaque psoriasis. J of Skin [Internet]. 2023Mar.13 [cited 2024Sep.20];7(2):s135. Available from: https://dermsquared.com/skin/article/view/2006